Friday, July 6, 2007/
Sleep-disordered breathing problems are a big problem, and one that ResMed has been successfully treating. With estimates that the disorder is only 7% diagnosed, the potential market for ResMed is huge.
Watch Paul Eisen from medical technology company ResMed talk about the development of the company’s technology and products for the screening, treatment and long-term management of sleep-disordered breathing and other respiratory disorders.
Founded in 1989, the company today employs 2500 people. Listed here and in the US, its turnover tops $600 million a year, with 97% of revenue coming from exports. The global company has distributors in 65 countries.
Senior vice president Paul Eisen says that research has shown that about 7–8% of the world’s population suffer from some form of sleep-disordered breathing, or obstructive sleep apnea, which translates to hundreds of millions of potential customers.
Your Business Success – Sunday mornings, 8.30am on the Nine Network – provides practical business advice from Australia’s leading entrepreneurs applied to real-life businesses. Each week a different leading entrepreneur shares their business knowledge: including Maxine Horn of Fone Zone, Brian Singer of Rip Curl, Paul Cave of BridgeClimb and Geoff Harris of Flight Centre.